MAAT PHARMA SACA (MAAT.PA) Forecast, Price Target & Analyst Ratings

EPA:MAAT • FR0012634822

Current stock price

7.02 EUR
+0.14 (+2.03%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MAAT PHARMA SACA (MAAT.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€17.27
+ 145.97% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 30, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.27%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€17.27
Upside
+ 145.97%
From current price of €7.02 to mean target of €17.27, Based on 11 analyst forecasts
Low
€13.13
Median
€17.34
High
€22.05

Price Target Revisions

1 Month
0.00%
3 Months
-3.27%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for MAAT.PA. The average price target is 17.27 EUR. This implies a price increase of 145.97% is expected in the next year compared to the current price of 7.02.
The average price target has been revised downward by 3.27% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MAAT Current Analyst RatingMAAT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

MAAT Historical Analyst RatingsMAAT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
87.27%
MAAT.PA was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about MAAT.PA.
In the previous month the buy percentage consensus was at a similar level.
MAAT.PA was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-04-07STIFEL EUROPEMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 30, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MAAT.PA revenue by date.MAAT.PA revenue by date.
1.43M
47.12%		2.228M
55.80%		3.216M
44.34%		13.233M
311.47%		15.047M
13.71%		20.91M
38.96%		96.025M
359.23%		201.25M
109.58%		350.93M
74.38%		474.25M
35.14%		604.4M
27.44%
EBITDA
YoY % growth
MAAT.PA ebitda by date.MAAT.PA ebitda by date.
-13.128M
-53.27%		-19.072M
-45.28%		-26.736M
-40.18%		-25.245M
5.58%		-29.045M
-15.05%		-36.686M
-26.31%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
MAAT.PA ebit by date.MAAT.PA ebit by date.
-13.557M
-52.45%		-19.943M
-47.10%		-28.428M
-42.55%		-25.514M
10.25%		-29.311M
-14.88%		-27.201M
7.20%		198.099K
100.73%		68.245M
34,350.01%		134.61M
97.25%		215.43M
60.04%		303.78M
41.01%
Operating Margin
MAAT.PA operating margin by date.MAAT.PA operating margin by date.
-948.04%-895.11%-883.96%-192.81%-194.79%-130.09%0.21%33.91%38.36%45.43%50.26%
EPS
YoY % growth
MAAT.PA eps by date.MAAT.PA eps by date.
N/A
20.24%		N/A
-37.87%		N/A
-12.99%		-3.29
-58.33%		-3.41
-3.77%		-3.39
0.62%		N/AN/AN/AN/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MAAT.PA Yearly Revenue VS EstimatesMAAT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
MAAT.PA Yearly EPS VS EstimatesMAAT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-17.75%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
78.25%
Revenue Next 5 Year
122.48%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-9.91%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MAAT PHARMA SACA / MAAT.PA Forecast FAQ

What is the average price target for MAAT PHARMA SACA (MAAT.PA) stock?

11 analysts have analysed MAAT.PA and the average price target is 17.27 EUR. This implies a price increase of 145.97% is expected in the next year compared to the current price of 7.02.

When does MAAT PHARMA SACA (MAAT.PA) report earnings?

MAAT PHARMA SACA (MAAT.PA) will report earnings on 2026-03-30.

What is the consensus rating for MAAT stock?

The consensus rating for MAAT PHARMA SACA (MAAT.PA) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.